Germany Defends Lower Drug Prices as US Probe Threatens New Tariffs
Updated
Updated · Bloomberg · Jun 24
Germany Defends Lower Drug Prices as US Probe Threatens New Tariffs
3 articles · Updated · Bloomberg · Jun 24
Summary
Berlin said it will press ahead with plans to force deeper medicine discounts from pharmaceutical companies despite a US trade probe announced last week.
Germany’s health ministry called the US accusation of unfair trade practices “unfounded” and said lower prices are needed to curb unsustainable costs in the public healthcare system.
The US investigation raises the risk of fresh tariffs, setting up a trade clash over how Germany funds and prices medicines.